SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Wellness and beauty brand Kloris closes in on equity crowdfunding target

    By

    UK CBD business Kloris is closing in on its crowdfunding target.

    The beauty and wellness brand is seeking to expand by attracting investors through the Seedrs fundraising platform.

    Founded in 2018, Kloris’ products are already stocked in big high street retailers like Boots and Selfridges.

    The company set itself a target of raising £250,000 via Seedrs and, at time of writing, is around £15,000 away with 22 days left until the investment deadline.

    Kloris reported revenue growth of 172% in the last year and is valued at around £6.1m.

    Co-founder Kim Smith said: “With over 90% funded at this stage of the campaign we are thrilled at the shared excitement and interest within this space.”

    Kloris co-founder Kim Smith

    The company becomes the latest in the CBD space to turn to Seedrs to try and attract investment.

    Online marketplace Alphagreen and and CBD craft beer company Cannabrew are among companies which have already turned to the crowdfunding platform.

    Founded in 2012, the London-based business allows companies to raise equity by selling a stake in the company through its digital market.

    Smith previously commented on Seedrs: “Throughout this time we have had many inquiries about the opportunity to invest in us, as consumers become more educated about putting their money into businesses that match their ethics and interests.

    “After such a positive year of growth and innovative product launches, now feels like the perfect time to invite our loyal customer base to be part of the ongoing KLORIS journey. We are thrilled to launch our first crowdfund with Seedrs.”

    [activecampaign form=31]

    Sean Seddon

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free